Newsroom
D’Ornano+Co was part of the Jury of the CFNEWS Tech Awards 2021
Why is EBITDA dead ? Op-ed in Les Echos 30 September 2021
SEO automation expert Botify completes a $55m Series C round
Wansquare featured Raphaëlle d’Ornano and the origin of D’Ornano + Co.
One billion in investments confirmed in the first half of 2021
D’Ornano + Co. continues to strengthen leadership team
Consulting: D’Ornano + Co expands international footprint
D’Ornano + Co. advised CAPZA in its buy-out operation of European film industry player Dubbing Brothers
French PE firm CAPZA to take a minority stake in French cybersecurity leader Advens
D’Ornano + Co. welcomes Thomas Priolet as Associate Partner
“Modern Private Investors” – FrenchFounders Rebound Summit #2 – April 29, 2021
How to confirm value creation in Technological build-ups – Capital Finance, 09 April 2021
Raphaëlle D’Ornano tells French founders why they should start preparing for a SPAC now
Smoove and Zoov merge and give birth to a European leader in MobilityTech
Explore completes second bolt-on with Societeinfo.com
Tekyn raises $7M+ Series A
D’Ornano + Co. advises Eurazeo Growth as it leads a €90m Series D in Payfit
13 of French Tech 40/120 2021 accompanied by D’Ornano + Co.
D’Ornano + Co. advises Magellan Partners in its bolt-on of Keralia Consulting
D’Ornano + Co. advises Montefiore Investment in its investment in Côté Sushi
D’Ornano + Co. featured as a leading Transaction Services Player in France, and in the Top 3 in Venture/Growth deals
D'Ornano + Co....
D’Ornano + Co. advises The Carlyle Group and Fintech VC NewAlpha AM in their joint investment in AI leader SESAMm
D’Ornano + Co. advises AI company Cornis in its sale to Groupe Sites.
Cécile Auvieux joins D’Ornano + Co. as IP/IT lawyer
D’Ornano + Co. advises Singular as it leads a 35m€ Series B in Indy (ex. Georges.Tech)
D’Ornano + Co. advised client experience leader Odity in its acquisition of ASM
D’Ornano + Co. advises B&Capital as it takes the relay of Latour in French leading manufacturer of swimming pool equipment.
Des investisseurs américains exigeants envers la “Tech” française – L’AGEFI, 4.12.2020
D’Ornano + Co. advised European Digital Group in the context of its acquisition of Orès Group
D’Ornano + Co. advised LBO France in the context of the €5m Series B fundraising of Zeplug
“La « French Tech » fait fi de la crise du Covid” – L’AGEFI, 19/11/2020
D’Ornano + Co. advised April Group in the context of their acquisition of comparison platform Comparadise.
D’Ornano + Co. advised ArtNova and co-investors in the context of the €5,85m Series A fundraising of Emissive.
D’Ornano + Co. advised François Feijoo and co-investors in the context of the restructuring of André.
D’Ornano + Co. advised Sagard and co-investors in a €40m fundraising for pharmaceutical company Laboratoires Delbert.
D’Ornano + Co. advised ProductLife Group in the context of their acquisition of Axpharma.
D’Ornano + Co. advised PE backed company Metaline in the context of their acquisition of Aptech.
D’Ornano + Co. advised Capagro and co-investors in €7m Series A round for animal nutrition’s company Japhy.
D’Ornano + Co. welcomes Yann Auregan as Associate Partner
D’Ornano + Co. advises Cipio Partners and Ventech in their series B investment in French manufacturer of Oled micro-screens, MicroOled
D’Ornano + Co. advised Gilde Healthcare and co-investors in $60m growth round on HealthTech scale-up Withings
“Fonder et développer un cabinet d’avocats de référence”
Law blog Anomia...
L’économie de la distance: loin des yeux, près du cœur de métier?
Portrait of Raphaëlle d’Ornano in Private Equity Magazine (June 20)
D’Ornano + Co. advises BlackRock, Bpifrance and co-investors in the context of their $190m investment in ContentSquare
New ways to assess the scale-up value creation in a post Covid-19 era. Register now!
« TECH – Le capital-risque et le LBO convergent » Florent Le Quintrec
D’Ornano + Co. advises Korelya Capital and co-investors in the context of their investment
Raphaëlle d’Ornano, Founder + Managing Partner of D’Ornano + Co., on work-life balance
“Insurtech M&A: key considerations for creating value in a disrupted environment”
D’Ornano + Co. advised Trocadéro Capital in the context of its investment in Flexifleet.
« L’Etat cajole le capital-investissement » Florent Le Quintrec
« Les acteurs phares de la Tech se livrent » – CFNews magazine février 2020
Nicolas Bayle is appointed Partner in Transaction Services at D’Ornano + Co.
D’Ornano + Co. advised ISAl in the context of its investment in Pandat Finance.
D’Ornano + Co. advised Extens and Geneo Capital in the context of their investment in Hoppen.
D’Ornano + Co. advised Gaia Capital in their first investment in Welcome to the Jungle
D’Ornano + Co. advised PE backed company Eva Group in the context of their acquisition of Lineon.
D’Ornano + Co. advises Hi-Inov, Cipio Partners and Entrepreneur Venture in their €17M
D’Ornano + Co. advises NewAlpha in their €4M investment in Fintech HelloPrêt.
“Les imprévus juridiques des levées de fonds: attention aux deal breakers!” – Le Figaro – September 18, 2019.
D’Ornano + Co. advises Montefiore Investment in their LBO in digital marketing company
D’Ornano + Co. advises Tikehau Capital in their LBOter in construction services Groupe Rougnon.
“Les enjeux des opérations de build-up” – Option Finance – July 19, 2019
D’Ornano + Co. advises Partech in the context of their investment In Bitrise.io in a total $20M series B.
D’Ornano + Co. advises BpiFrance in the context of their investment In Vestiaire Collective in a total €40M series E.
D’Ornano + Co. advises Eurazeo Growth and co-investors in the context of their investment In Payfit in a total €70M series B.
Raphaëlle d’Ornano, Founder of D’Ornano + Co., on new due diligence risks + criterias at the occasion of the 3rd edition of the Option Finance Private Equity summit.
D’Ornano + Co. advises Idinvest in their 21M€ investment in LumApps.
D’Ornano + Co. advises Bpifrance and co-investors in their €36M investment in 360Learning.
D’Ornano + Co. advised PE backed company SGH Healthcaring in the context of their acquisition of Eskiss + Dosapharm.